Pre-Exposure Prophylaxis (PrEP)

Pre-exposure prophylaxis (PrEP) is an antiretroviral therapy-based HIV prevention strategy to prevent or at least reduce the risk of HIV infection in adults who have not been infected with the virus but are at high risk of infection.

Use of antiretroviral medication for PrEP has been approved in the European Union. As an additional prevention option it has the potential to reduce HIV transmission and contribute to reversing the increase in new infections in Europe.

Read more


Pre-exposure prophylaxis in the EU/EEA. PrEP service delivery and monitoring: minimum standards and key principles

15 Nov 2018 - 16 Nov 2018
Stockholm, Sweden


ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe

Technical report -


Pre-exposure prophylaxis to prevent HIV among MSM in Europe

ECDC comment -


Pre-exposure prophylaxis for HIV in Europe

ECDC comment -